Skip to main content
Journal cover image

Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea.

Publication ,  Journal Article
Min, YG; Lee, S-Y; Lim, E; Park, M-Y; Kim, D-H; Byun, JM; Koh, Y; Hong, J; Shin, D-Y; Yoon, S-S; Sung, J-J; Oh, SB; Kim, I
Published in: The journal of pain
September 2024

Bortezomib-induced neuropathic pain (BINP) poses a challenge in multiple myeloma (MM) treatment. Genetic factors play a key role in BINP susceptibility, but research has predominantly focused on Caucasian populations. This research explored novel genetic risk loci and pathways associated with BINP development in Korean MM patients while evaluating the reproducibility of variants from Caucasians. Clinical data and buffy coat samples from 185 MM patients on bortezomib were collected. The cohort was split into discovery and validation cohorts through random stratification of clinical risk factors for BINP. Genome-wide association study was performed on the discovery cohort (n = 74) with Infinium Global Screening Array-24 v3.0 BeadChip (654,027 single nucleotide polymorphism [SNPs]). Relevant biological pathways were identified using the pathway scoring algorithm. The top 20 SNPs were validated in the validation cohort (n = 111). Previously reported SNPs were validated in the entire cohort (n = 185). Pathway analysis of the genome-wide association study results identified 31 relevant pathways, including immune systems and endosomal vacuolar pathways. Among the top 20 SNPs from the discovery cohort, 16 were replicated, which included intronic variants in ASIC2 and SMOC2, recently implicated in nociception, as well as intergenic variants or long noncoding RNAs. None of the 17 previously reported SNPs remained significant in our cohort (rs2274578, P = .085). This study represents the first investigation of novel genetic loci and biological pathways associated with BINP occurrence. Our findings, in conjunction with existing Caucasian studies, expand the understanding of personalized risk prediction and disease mechanisms. PERSPECTIVE: This article is the first to explore novel genetic loci and pathways linked to BINP in Korean MM patients, offering novel insights beyond the existing research focused on Caucasian populations into personalized risk assessment and therapeutic strategies of BINP.

Duke Scholars

Published In

The journal of pain

DOI

EISSN

1528-8447

ISSN

1526-5900

Publication Date

September 2024

Volume

25

Issue

9

Start / End Page

104552

Related Subject Headings

  • Risk Factors
  • Republic of Korea
  • Polymorphism, Single Nucleotide
  • Neuralgia
  • Multiple Myeloma
  • Middle Aged
  • Male
  • Humans
  • Genome-Wide Association Study
  • Genetic Predisposition to Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Min, Y. G., Lee, S.-Y., Lim, E., Park, M.-Y., Kim, D.-H., Byun, J. M., … Kim, I. (2024). Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea. The Journal of Pain, 25(9), 104552. https://doi.org/10.1016/j.jpain.2024.104552
Min, Young Gi, Sung-Yeoun Lee, Ehyun Lim, Mi-Young Park, Dong-Ho Kim, Ja Min Byun, Youngil Koh, et al. “Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea.The Journal of Pain 25, no. 9 (September 2024): 104552. https://doi.org/10.1016/j.jpain.2024.104552.
Min YG, Lee S-Y, Lim E, Park M-Y, Kim D-H, Byun JM, et al. Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea. The journal of pain. 2024 Sep;25(9):104552.
Min, Young Gi, et al. “Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea.The Journal of Pain, vol. 25, no. 9, Sept. 2024, p. 104552. Epmc, doi:10.1016/j.jpain.2024.104552.
Min YG, Lee S-Y, Lim E, Park M-Y, Kim D-H, Byun JM, Koh Y, Hong J, Shin D-Y, Yoon S-S, Sung J-J, Oh SB, Kim I. Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea. The journal of pain. 2024 Sep;25(9):104552.
Journal cover image

Published In

The journal of pain

DOI

EISSN

1528-8447

ISSN

1526-5900

Publication Date

September 2024

Volume

25

Issue

9

Start / End Page

104552

Related Subject Headings

  • Risk Factors
  • Republic of Korea
  • Polymorphism, Single Nucleotide
  • Neuralgia
  • Multiple Myeloma
  • Middle Aged
  • Male
  • Humans
  • Genome-Wide Association Study
  • Genetic Predisposition to Disease